161 related articles for article (PubMed ID: 23478952)
1. Pharmacokinetic interaction between telaprevir and methadone.
van Heeswijk R; Verboven P; Vandevoorde A; Vinck P; Snoeys J; Boogaerts G; De Paepe E; Van Solingen-Ristea R; Witek J; Garg V
Antimicrob Agents Chemother; 2013 May; 57(5):2304-9. PubMed ID: 23478952
[TBL] [Abstract][Full Text] [Related]
2. Effect of tenofovir disoproxil fumarate on the pharmacokinetics and pharmacodynamics of total, R-, and S-methadone.
Smith PF; Kearney BP; Liaw S; Cloen D; Bullock JM; Haas CE; Yale K; Booker BM; Berenson CS; Coakley DF; Flaherty JF
Pharmacotherapy; 2004 Aug; 24(8):970-7. PubMed ID: 15338845
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects.
Cao YJ; Smith PF; Wire MB; Lou Y; Lancaster CT; Causon RC; Bigelow GE; Martinez E; Fuchs EJ; Radebaugh C; McCabe S; Hendrix CW
Pharmacotherapy; 2008 Jul; 28(7):863-74. PubMed ID: 18576901
[TBL] [Abstract][Full Text] [Related]
4. Effect of steady-state faldaprevir on the pharmacokinetics of steady-state methadone and buprenorphine-naloxone in subjects receiving stable addiction management therapy.
Joseph D; Schobelock MJ; Riesenberg RR; Vince BD; Webster LR; Adeniji A; Elgadi M; Huang F
Antimicrob Agents Chemother; 2015 Jan; 59(1):498-504. PubMed ID: 25385094
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with amprenavir in opioid-dependent subjects.
Hendrix CW; Wakeford J; Wire MB; Lou Y; Bigelow GE; Martinez E; Christopher J; Fuchs EJ; Snidow JW
Pharmacotherapy; 2004 Sep; 24(9):1110-21. PubMed ID: 15460171
[TBL] [Abstract][Full Text] [Related]
6. Lack of clinically significant pharmacokinetic interaction between the thrombopoietin receptor agonist eltrombopag and hepatitis C virus protease inhibitors boceprevir and telaprevir.
Wire MB; Fang L; Hussaini A; Kleha JF; Theodore D
Antimicrob Agents Chemother; 2014 Nov; 58(11):6704-9. PubMed ID: 25155600
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy.
Hulskotte EG; Bruce RD; Feng HP; Webster LR; Xuan F; Lin WH; O'Mara E; Wagner JA; Butterton JR
Eur J Clin Pharmacol; 2015 Mar; 71(3):303-11. PubMed ID: 25666027
[TBL] [Abstract][Full Text] [Related]
8. The effect of rilpivirine on the pharmacokinetics of methadone in HIV-negative volunteers.
Crauwels HM; van Heeswijk RP; Vandevoorde A; Buelens A; Stevens M; Hoetelmans RM
J Clin Pharmacol; 2014 Feb; 54(2):133-40. PubMed ID: 24203510
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the interactions between methadone and elvitegravir-cobicistat in subjects receiving chronic methadone maintenance.
Bruce RD; Winkle P; Custodio JM; Wei X; Rhee MS; Kearney BP; Ramanathan S; Friedland GH
Antimicrob Agents Chemother; 2013 Dec; 57(12):6154-7. PubMed ID: 24080665
[TBL] [Abstract][Full Text] [Related]
10. Major depressive disorder and patient satisfaction in relation to methadone pharmacokinetics and pharmacodynamics in stabilized methadone maintenance patients.
Elkader AK; Brands B; Dunn E; Selby P; Sproule BA
J Clin Psychopharmacol; 2009 Feb; 29(1):77-81. PubMed ID: 19142113
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic-pharmacodynamic modeling of mood and withdrawal symptoms in relation to plasma concentrations of methadone in patients undergoing methadone maintenance treatment.
Shiran MR; Lennard MS; Iqbal MZ; Lagundoye O; Seivewright N; Tucker GT; Rostami-Hodjegan A
J Clin Psychopharmacol; 2012 Oct; 32(5):666-71. PubMed ID: 22926601
[TBL] [Abstract][Full Text] [Related]
12. Effects of pegylated interferon alfa-2b on the pharmacokinetic and pharmacodynamic properties of methadone: a prospective, nonrandomized, crossover study in patients coinfected with hepatitis C and HIV receiving methadone maintenance treatment.
Berk SI; Litwin AH; Arnsten JH; Du E; Soloway I; Gourevitch MN
Clin Ther; 2007 Jan; 29(1):131-8. PubMed ID: 17379053
[TBL] [Abstract][Full Text] [Related]
13. Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients.
Foster DJ; Somogyi AA; Dyer KR; White JM; Bochner F
Br J Clin Pharmacol; 2000 Nov; 50(5):427-40. PubMed ID: 11069437
[TBL] [Abstract][Full Text] [Related]
14. Effects of boceprevir and telaprevir on the pharmacokinetics of dolutegravir.
Johnson M; Borland J; Chen S; Savina P; Wynne B; Piscitelli S
Br J Clin Pharmacol; 2014 Nov; 78(5):1043-9. PubMed ID: 24838177
[TBL] [Abstract][Full Text] [Related]
15. Effect of lersivirine co-administration on pharmacokinetics of methadone in healthy volunteers.
Vourvahis M; Wang R; Gruener DM; Bruce RD; Haider S; Tawadrous M
Drug Alcohol Depend; 2012 Nov; 126(1-2):183-8. PubMed ID: 22682979
[TBL] [Abstract][Full Text] [Related]
16. Effect of telaprevir on the pharmacokinetics of buprenorphine in volunteers on stable buprenorphine/naloxone maintenance therapy.
Luo X; Trevejo J; van Heeswijk RP; Smith F; Garg V
Antimicrob Agents Chemother; 2012 Jul; 56(7):3641-7. PubMed ID: 22564847
[TBL] [Abstract][Full Text] [Related]
17. Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships.
Dyer KR; Foster DJ; White JM; Somogyi AA; Menelaou A; Bochner F
Clin Pharmacol Ther; 1999 Jun; 65(6):685-94. PubMed ID: 10391674
[TBL] [Abstract][Full Text] [Related]
18. The effects of once-daily saquinavir/minidose ritonavir on the pharmacokinetics of methadone.
Shelton MJ; Cloen D; DiFrancesco R; Berenson CS; Esch A; de Caprariis PJ; Palic B; Schur JL; Buggé CJ; Ljungqvist A; Espinosa O; Hewitt RG
J Clin Pharmacol; 2004 Mar; 44(3):293-304. PubMed ID: 14973306
[TBL] [Abstract][Full Text] [Related]
19. Dolutegravir does not affect methadone pharmacokinetics in opioid-dependent, HIV-seronegative subjects.
Song I; Mark S; Chen S; Savina P; Wajima T; Peppercorn A; Bala U; Geoffroy P; Piscitelli S
Drug Alcohol Depend; 2013 Dec; 133(2):781-4. PubMed ID: 24018316
[TBL] [Abstract][Full Text] [Related]
20. Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction.
Friedland G; Andrews L; Schreibman T; Agarwala S; Daley L; Child M; Shi J; Wang Y; O'Mara E
AIDS; 2005 Oct; 19(15):1635-41. PubMed ID: 16184033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
